Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Servier Selects Banook CI for Imaging Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

Servier Selects Banook CI for Imaging Services

Will evaluate anti-tumor activity in Phase I breast cancer trial

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Banook Central Imaging (Banook CI) has been selected by Servier to assess the potential anti-tumor activity of a novel monoclonal antibody based on the RECIST 1.1 (Response Evaluation Criteria in Solid Tumors) and Immune-Related Response criteria (IrRC) in a multicenter Phase I study in patients with breast cancer. The study will also incorporate the use of Tumor Growth Rates (TGR), an assessment that provides the growth rate before and after treatment.
 
Banook CI will use their comprehensive imaging core lab services, including a specialized radiologic review and analysis of all images. Also, Banook’s software will support and automate all the necessary tasks for the follow-up of the radiologic exams, allowing readers to focus on accurate image interpretation and response analysis.
 
“We are delighted to start this new collaboration with Servier,” said Dr. Pascal Voiriot, founder and chief executive officer at Banook CI. “Our customers increasingly attempt to include new methodologies such as TGR or IrRC in their clinical programs. We are always looking for innovative solutions aimed at better and earlier evaluation of the response of patients to the new therapeutic approaches for cancer. Banook CI is setting the bar for the industry.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics